68695-48-7

Basic information

• Product Name: DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT
• Synonyms: DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT;Tetra-n-butylammonium Di-tert-butylphosphate;Tetrabutylammonium di-tert-butyl phosphate;di-tert-butyl phosphate, di-tert-butylphosphate;di-tert-butyl phosphoric acid tetra-n-butylammonium salt, tetra-n-butylammonium di-tert-butylphosphate, tetrabuthylammonium di-tert-butyl-phosphate, tetrabutylammonium di-tert-butyl phosphate, tetrabutylammonium di-tert-butylphosphate, tetrabutylammonium;tetrabutylammonium salt
• CAS NO: 68695-48-7
• Molecular Formula: C₈H₁₈O₄P*C₁₆H₃₆N
• Molecular Weight: 451.663621
• Mol File: 68695-48-7.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT(CAS DataBase Reference)
• NIST Chemistry Reference: DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT(68695-48-7)
• EPA Substance Registry System: DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT(68695-48-7)

Safety Data

• Hazardous Substances Data: 68695-48-7(Hazardous Substances Data)

Usage

General Description

DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT is a compound consisting of di-tert-butylphosphate, which is an organophosphate compound, and tetrabutylammonium, which is a quaternary ammonium compound. This chemical combination is commonly used as a solvent or extractant in various industrial processes, such as in the extraction of rare earth metals from ores or in the separation of organic compounds. It is also used as an electrolyte in some types of batteries. DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT is known for its high solubility in organic solvents and its ability to form stable complexes with metal ions, making it useful in various chemical separation and purification processes. However, it is important to handle this compound with care, as it can be toxic and harmful to the environment if not properly managed.

InChI:InChI=1/C16H36N.C8H19O4P/c1-5-9-13-17(14-10-6-2,15-11-7-3)16-12-8-4;1-7(2,3)11-13(9,10)12-8(4,5)6/h5-16H2,1-4H3;1-6H3,(H,9,10)/q+1;/p-1

Upstream product

• 32503-27-8 tetra(n-butyl)ammonium hydrogensulfate 
• 33494-80-3 potassium di-tert-butylphosphate 
• 33494-81-4 phosphoric acid di-tert-butyl ester 
• 13086-84-5 di-tert-butyl phosphite 
• 13086-84-5 di-tert-butyl phosphite 
• 2052-49-5 tetra(n-butyl)ammonium hydroxide 

Downstream Products

• 3393-77-9 bis(4-methoxyphenyl)sulfide 
• 110348-50-0 4-Methoxy-benzenethiolatetetrabutyl-ammonium; 
• 885228-14-8 benzyl (2-((di-tert-butoxyphosphoryl)oxy)ethyl)carbamate 
• 1401907-80-9 methyl 3-(((di-tert-butoxyphosphoryl)oxy)methyl)benzoate 
• 1584715-93-4 ((S)-3-((R)-2-((S)-1-amino-3-cyclopropyl-1-oxopropan-2-yl)-5,5,5-trifluoropentanamido)-9-fluoro-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)methyl di-tert-butyl phosphate 
• 1367455-49-9 [2-[2-amino-4-(isoindoline-2-carbonyl)quinazolin-6-yl]-4,5-difluorophenyl]methyl di-tert-butyl phosphate 

Relevant articles and documents

4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator

Compounds and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the neurokinin (NK1) receptor, based on 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)3yridine-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium and pharmaceutically acceptable salts thereof.

PHENYLQUINAZOLINE DERIVATIVES

Novel quinazolinamide derivatives of the formula (I), in which R1-R43 and X have the meanings indicated in claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.

MONO-LYSINE SALTS OF AZOLE COMPOUNDS

Mono-lysine salts of triazole compounds having a secondary or tertiary hydroxy group are provided. More particularly, the new water-soluble triazole antifungal mono-lysine salt compounds, or solvates thereof, are provided having the general formula I: wherein A in formula I represents the non-hydroxy portion of a triazole antifungal compound of the type containing a secondary or tertiary hydroxyl group. R and R1 in formula I can each be a hydrogen atom or an alkyl group having one to six carbon atoms. The novel water-soluble azole compounds are useful for the treatment of fungal infections and can be administered orally, topically and parenterally.